Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Queensland Health
Chinese Patent Office
Cipla
Federal Trade Commission
US Army
Harvard Business School
Covington

Generated: April 20, 2018

DrugPatentWatch Database Preview

EXCEDRIN (MIGRAINE) Drug Profile

« Back to Dashboard

Which patents cover Excedrin (migraine), and what generic alternatives are available?

Excedrin (migraine) is a drug marketed by Glaxosmithkline Cons and is included in one NDA.

The generic ingredient in EXCEDRIN (MIGRAINE) is acetaminophen; aspirin; caffeine. There are sixty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; aspirin; caffeine profile page.
Drug patent expirations by year for EXCEDRIN (MIGRAINE)
Synonyms for EXCEDRIN (MIGRAINE)
52624-46-1
83535-74-4
Acetaminophen / aspirin / caffeine
Acetaminophen Mixture With Aspirin And Caffeine
ACETAMINOPHEN; ASPIRIN; CAFFEINE
Acetyl Salicylic Acid Paracetamol Caffeine
Anadin Extra
Anfengapilin
APC-AC
BENZOIC ACID,2-(ACETYLOXY)-,MIXT. WITH 3,7-DIHYDRO-1,3,7-TRIMETHYL-1H-PURINE-2,6- DIONE AND N-(4-HYDROXYPHENYL)ACETAMIDE
BKMBGNWZSQNIKU-UHFFFAOYSA-N
C9H8O4.C8H10N4O2.C8H9NO2
Cibalena A
Dikalm
Excedrin extra strength
LS-178504
NeoCitramonum
Neuranidal
OR349259
SCHEMBL4063268
Thomapyrin N

US Patents and Regulatory Information for EXCEDRIN (MIGRAINE)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Cons EXCEDRIN (MIGRAINE) acetaminophen; aspirin; caffeine TABLET;ORAL 020802-001 Jan 14, 1998 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for EXCEDRIN (MIGRAINE)

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Cons EXCEDRIN (MIGRAINE) acetaminophen; aspirin; caffeine TABLET;ORAL 020802-001 Jan 14, 1998 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Cons EXCEDRIN (MIGRAINE) acetaminophen; aspirin; caffeine TABLET;ORAL 020802-001 Jan 14, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Cantor Fitzgerald
Daiichi Sankyo
Baxter
Chinese Patent Office
Harvard Business School
US Army
Cipla
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.